Hematology On Air Global Event 2023


­čŚô November 7th, 2023 | ­čĽÉ 17:00 – 21:30 CET | ­čîÉ VIRTUAL

Join us in our Global Hematology On Air Assembly, for a full day of medical content!
Over 10 hematology superstars will lead a day-long live broadcast!

About the Event

Hematology on Air aims to bring together prominent experts from around the world to discuss the latest advancements, challenges, and future directions in hematology research and clinical practice.
The meeting will allow the speakers to share their insights and research findings with a global audience. These insights will focus on cutting-edge developments, like AI in clinical decision-making, clonal hematopoiesis, novel treatments for various hematologic diseases, and emerging therapies.
For medical professionals, this meeting serves as a platform for continuing education. Attendees can stay updated with the most recent trends, therapeutic approaches, and innovative technologies being used in hematology.
The ultimate goal is to improve patient outcomes. By discussing the novel treatment approaches, such as CAR-T cell development, bispecific antibodies, and precision medicine, the meeting aims to explore how these innovations can be integrated into clinical practice for the benefit of patients.

Scientific Directors

Speakers

Agenda

Hematology On Air Global Event 2023
5:00:00 PM

Opening

M. Della Porta, T. Haferlach
5:03:00 PM

Intro to the daily agenda & Intro to first session

Humanitas Cancer Center
M. Della Porta
5:10:00 PM

Clinical implementation of artificial intelligence to improve clinical decision making process in hematology

MLL, Germany
T. Haferlach
5:35:00 PM

Clonal hematopoiesis: new insights and clinical implications

University of Cambridge
G. Vassiliou
6:02:00 PM

New drug and transplant therapies in AML

University of Birmingham
C. Craddock
6:27:00 PM

Novel therapies and combinations in chronic lymphocytic leukemia (CLL)

San Raffaele Hospital, Milan, Italy
P. Ghia
6:54:00 PM

Treatment approach in myelodysplastic syndromes (MDS) in the time of precision medicine

Yale University, US
A. Zeidan
7:19:00 PM

High or Low? Assessing disease risk in multiple myeloma

University of Navarra, Spain
B. Paiva
7:46:00 PM

CAR-T cell development in multiple myeloma

University of Paris, FR
M. Mohty
8:11:00 PM

Bi-specific antibodies for the treatment of lymphomas

University of Bologna
P. L. Zinzani
8:36:00 PM

Bispecific antibodies for the treatment of lymphomas: promises and challenges

Humanitas University
C. Carlo-Stella
9:00:00 PM

Round table and discussion

9:26:00 PM

Closing

M. Della Porta, T. Haferlach
Log in to watch the livestream

Partners

with the non-conditional support of: